167 related articles for article (PubMed ID: 38446361)
1. Targeting S100A9 Prevents β-Adrenergic Activation-Induced Cardiac Injury.
Liu J; Chen X; Zeng L; Zhang L; Wang F; Peng C; Huang X; Li S; Liu Y; Shou W; Li X; Cao D
Inflammation; 2024 Apr; 47(2):789-806. PubMed ID: 38446361
[TBL] [Abstract][Full Text] [Related]
2. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
[TBL] [Abstract][Full Text] [Related]
3. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
4. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury.
Li Y; Chen B; Yang X; Zhang C; Jiao Y; Li P; Liu Y; Li Z; Qiao B; Bond Lau W; Ma XL; Du J
Circulation; 2019 Aug; 140(9):751-764. PubMed ID: 31220942
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
6. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
[TBL] [Abstract][Full Text] [Related]
7. S100a8/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1/2-Drp1-mediated mitochondrial fission and respiratory dysfunction.
Wu F; Zhang YT; Teng F; Li HH; Guo SB
Int Immunopharmacol; 2023 Feb; 115():109716. PubMed ID: 36652759
[TBL] [Abstract][Full Text] [Related]
8. S100A8/9 modulates perturbation and glycolysis of macrophages in allergic asthma mice.
Ji X; Nie C; Yao Y; Ma Y; Huang H; Hao C
PeerJ; 2024; 12():e17106. PubMed ID: 38646478
[TBL] [Abstract][Full Text] [Related]
9. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
10. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.
Boyd JH; Kan B; Roberts H; Wang Y; Walley KR
Circ Res; 2008 May; 102(10):1239-46. PubMed ID: 18403730
[TBL] [Abstract][Full Text] [Related]
11. S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice.
Yuan YP; Shen ZY; Teng T; Xu SC; Kong CY; Zeng XF; A Hofmann Bowman M; Yan L
J Am Heart Assoc; 2024 May; 13(10):e028006. PubMed ID: 38726894
[TBL] [Abstract][Full Text] [Related]
12. S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα.
Shi S; Yi JL
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3925-3935. PubMed ID: 29949169
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q
Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551
[TBL] [Abstract][Full Text] [Related]
14. Immune Resolution Dilemma: Host Antimicrobial Factor S100A8/A9 Modulates Inflammatory Collateral Tissue Damage During Disseminated Fungal Peritonitis.
Shankar M; Uwamahoro N; Backman E; Holmberg S; Niemiec MJ; Roth J; Vogl T; Urban CF
Front Immunol; 2021; 12():553911. PubMed ID: 33717058
[TBL] [Abstract][Full Text] [Related]
15. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
McNeill E; Hogg N
Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
[TBL] [Abstract][Full Text] [Related]
16. Salmonella pathogenicity island 1 knockdown confers protection against myocardial fibrosis and inflammation in uremic cardiomyopathy via down-regulation of S100 Calcium Binding Protein A8/A9 transcription.
Cai X; Hong L; Liu Y; Huang X; Lai H; Shao L
Ren Fail; 2022 Dec; 44(1):1819-1832. PubMed ID: 36299239
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
Marinković G; Grauen Larsen H; Yndigegn T; Szabo IA; Mares RG; de Camp L; Weiland M; Tomas L; Goncalves I; Nilsson J; Jovinge S; Schiopu A
Eur Heart J; 2019 Aug; 40(32):2713-2723. PubMed ID: 31292614
[TBL] [Abstract][Full Text] [Related]
18. S100A8 and S100A9 in Cancer.
Chen Y; Ouyang Y; Li Z; Wang X; Ma J
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615
[TBL] [Abstract][Full Text] [Related]
19. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models.
Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS
Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
Wei X; Wu B; Zhao J; Zeng Z; Xuan W; Cao S; Huang X; Asakura M; Xu D; Bin J; Kitakaze M; Liao Y
Circulation; 2015 Apr; 131(17):1506-17; discussion 1517. PubMed ID: 25820336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
